Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma

Published:2018-10-01 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Guo Xingliang,Jiang Hua,Shi Bizhi,Zhou Min,Zhang Honghong,Shi Zhimin,Du Guoxiu,Luo Hong,Wu Xiuqi,Wang Yi,Sun Ruixin,Li Zonghai

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference73 articles.

1. Vitamin D receptor gene methylation in hepatocellular carcinoma.;Abdalla;Gene,2018

2. CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges.;Bagley;Neuro Oncol.,2018

3. The PD1:PD-L1/2 pathway from discovery to clinical implementation.;Bardhan;Front. Immunol.,2016

4. Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples.;Baumhoer;Am. J. Clin. Pathol.,2008

5. Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager.;Bi;Oncotarget,2017

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for Improving CAR T Cell Persistence in Solid Tumors;Cancers;2024-08-16

2. Exploring Glypican-3 as a Molecular Target in Hepatocellular Carcinoma: Perspectives on Diagnosis and Precision Immunotherapy Strategies;Frontiers in Bioscience-Landmark;2024-07-24

3. Current application and future perspective of CRISPR/cas9 gene editing system mediated immune checkpoint for liver cancer treatment;Nanotechnology;2024-07-17

4. Non-viral expression of chimeric antigen receptors with multiplex gene editing in primary T cells;Frontiers in Bioengineering and Biotechnology;2024-05-31

5. Regulatory mechanisms of PD-1/PD-L1 in cancers;Molecular Cancer;2024-05-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3